Literature DB >> 17768102

Complement evasion of pathogens: common strategies are shared by diverse organisms.

Peter F Zipfel1, Reinhard Würzner, Christine Skerka.   

Abstract

Infectious diseases represent a major health problem. Based on the limited efficacy of existing drugs and vaccines and the increasing antibiotic resistance new strategies are needed to fight infectious diseases. A better understanding of pathogen-host interaction is one important aspect to identify new virulence factors and antimicrobial and anti-inflammatory compounds utilized by pathogens represent an additional source for effective anti-inflammatory compounds. Complement forms a major defense line against invading microbes, and pathogens have learned during evolution to breach this defense line. The characterization of how pathogens evade complement attack is a rapidly developing field of current research. Pathogens mimic host surfaces and bind host complement regulators. Similarly pathogens utilize a number of complement inhibitory molecules which help to evade complement attack and which display anti-inflammatory activity. The molecular identification of these molecules, as well as the functional characterization of their roles at the pathogen-host interface is an important and emerging field of infection biology. In addition, pathogens utilize multiple sets of such regulators as redundancy and multiplicity is important for immune and complement evasion. Here we summarize the current scenarios of this emerging field which identifies multiple virulence factors and complement evasion strategies, but which at the same time reveals common mechanisms for immune and complement defense.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17768102     DOI: 10.1016/j.molimm.2007.06.149

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  64 in total

1.  Plasminogen is a complement inhibitor.

Authors:  Diana Barthel; Susann Schindler; Peter F Zipfel
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

2.  Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells.

Authors:  Vaibhav Agarwal; Tauseef M Asmat; Shanshan Luo; Inga Jensch; Peter F Zipfel; Sven Hammerschmidt
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

3.  A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system.

Authors:  Monika Jusko; Jan Potempa; Abdulkarim Y Karim; Miroslaw Ksiazek; Kristian Riesbeck; Peter Garred; Sigrun Eick; Anna M Blom
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

Review 4.  Complement evasion by human pathogens.

Authors:  John D Lambris; Daniel Ricklin; Brian V Geisbrecht
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

5.  American Society of Nephrology clinical pathological conference.

Authors:  Kevin E Meyers; Helen Liapis; Mohamed G Atta
Journal:  Clin J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 8.237

Review 6.  Complement regulators and inhibitory proteins.

Authors:  Peter F Zipfel; Christine Skerka
Journal:  Nat Rev Immunol       Date:  2009-09-04       Impact factor: 53.106

7.  Vascular binding of a pathogen under shear force through mechanistically distinct sequential interactions with host macromolecules.

Authors:  Tara J Moriarty; Meiqing Shi; Yi-Pin Lin; Rhodaba Ebady; Hong Zhou; Tanya Odisho; Pierre-Olivier Hardy; Aydan Salman-Dilgimen; Jing Wu; Eric H Weening; Jon T Skare; Paul Kubes; John Leong; George Chaconas
Journal:  Mol Microbiol       Date:  2012-10-24       Impact factor: 3.501

8.  Analysis of the complement sensitivity of oral treponemes and the potential influence of FH binding, FH cleavage and dentilisin activity on the pathogenesis of periodontal disease.

Authors:  D P Miller; J V McDowell; J K Bell; M P Goetting-Minesky; J C Fenno; R T Marconi
Journal:  Mol Oral Microbiol       Date:  2014-06-03       Impact factor: 3.563

9.  Killing of Gram-negative bacteria with normal human serum and normal bovine serum: use of lysozyme and complement proteins in the death of Salmonella strains O48.

Authors:  G Bugla-Płoskońska; A Kiersnowski; B Futoma-Kołoch; W Doroszkiewicz
Journal:  Microb Ecol       Date:  2009-03-18       Impact factor: 4.552

Review 10.  aHUS caused by complement dysregulation: new therapies on the horizon.

Authors:  Aoife M Waters; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2010-06-18       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.